What's new

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 35, Status: Authorised

Apr 14, 2025 - 12:36
 0
Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 35, Status: Authorised
Human medicines European public assessment report (EPAR): Eliquis, apixaban, Date of authorisation: 18/05/2011, Revision: 35, Status: Authorised
Read More

Tags:

Previous Article

Will protectionism restrict automotive innovation in the US?

Next Article

PepsiCo bolsters FareShare partnership with £210k grant

Related Posts

Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0

Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitagliptin fumarate, Date of authorisation: 09/12/2021, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0

Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 25, 2025  0